A detailed history of Sectoral Asset Management Inc transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 15,650 shares of ITOS stock, worth $113,619. This represents 0.13% of its overall portfolio holdings.

Number of Shares
15,650
Previous 96,966 83.86%
Holding current value
$113,619
Previous $1.44 Million 88.94%
% of portfolio
0.13%
Previous 0.71%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.09 - $17.97 $820,478 - $1.46 Million
-81,316 Reduced 83.86%
15,650 $159,000
Q2 2024

Aug 13, 2024

SELL
$10.33 - $18.09 $382,210 - $669,330
-37,000 Reduced 27.62%
96,966 $1.44 Million
Q1 2024

May 14, 2024

SELL
$9.89 - $13.64 $851,430 - $1.17 Million
-86,090 Reduced 39.12%
133,966 $1.83 Million
Q4 2023

Feb 14, 2024

BUY
$8.57 - $11.06 $556,887 - $718,689
64,981 Added 41.9%
220,056 $2.41 Million
Q3 2023

Nov 14, 2023

BUY
$10.95 - $14.6 $93,064 - $124,085
8,499 Added 5.8%
155,075 $1.7 Million
Q2 2023

Aug 11, 2023

BUY
$12.93 - $18.05 $752,564 - $1.05 Million
58,203 Added 65.86%
146,576 $1.94 Million
Q1 2023

May 12, 2023

BUY
$13.02 - $22.62 $398,555 - $692,420
30,611 Added 53.0%
88,373 $1.2 Million
Q4 2022

Feb 10, 2023

BUY
$17.77 - $21.6 $1.03 Million - $1.25 Million
57,762 New
57,762 $1.13 Million
Q2 2022

Aug 15, 2022

SELL
$16.57 - $35.1 $1.43 Million - $3.03 Million
-86,250 Reduced 36.84%
147,900 $3.05 Million
Q1 2022

May 10, 2022

BUY
$31.92 - $47.45 $4.92 Million - $7.31 Million
154,150 Added 192.69%
234,150 $7.54 Million
Q4 2021

Feb 11, 2022

SELL
$26.23 - $47.86 $5.08 Million - $9.27 Million
-193,700 Reduced 70.77%
80,000 $3.73 Million
Q3 2021

Nov 15, 2021

BUY
$23.91 - $29.58 $6.36 Million - $7.87 Million
266,000 Added 3454.55%
273,700 $7.39 Million
Q2 2021

Aug 16, 2021

BUY
$17.9 - $36.1 $137,830 - $277,970
7,700 New
7,700 $198,000

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $258M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.